We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Postmarket Study Processes Topic of FDA Guidance
Postmarket Study Processes Topic of FDA Guidance
February 17, 2006
The FDA intends to conduct timely reviews of drugmakers' postmarketing commitment protocols, according to a new guidance on streamlining postmarket reporting procedures.